La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Kemper Corporation 5.875% Fixed-Rate Reset Junior Subordinated Debentures due 2062 a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Kemper Corporation 5.875% Fixed-Rate Reset Junior Subordinated Debentures due 2062..

Kemper Corporation 5.875% Fixed-Rate Reset Junior Subordinated Debentures due 2062 (NYSE:KMPB) Azioni, Catena delle Opzioni

Kemper Corporation 5.875% Fixed-Rate Reset Junior Subordinated Debentures due 2062

<a href="https://www.reuters.com/legal/government/us-lawmakers-renew-concerns-about-genscripts-ties-china-2025-07-08/">https://www.reuters.com/legal/government/us-lawmakers-renew-concerns-about-genscripts-ties-china-2025-07-08/</a>

News

General

LEGN

' US lawmakers renew concerns about GenScript's ties to China'- Reuters Exclusive

INHD

On July 4, Inno Holdings Enters Equity Purchase Agreement With Investors; Can Issue Up To $6M In Shares

Wag! Group Co. Amends Financing Agreement With Retriever LLC; Pursuant To Amendment, Reduces Liquidity Covenant And Restricts Use

Taylor Morrison Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMHC#NYSE">TMHC</a>) has outperformed the market over the past 5 years by 10.5% on an annualized basis producing an average annual return of 25.02%. Currently, Taylor Morrison Home has a market capitalization of $6.28 billion. 
Buying $100 In TMHC: If an investor had bought $100 of TMHC stock 5 years ago, it would be worth $290.98 today based on a price of $62.56 for TMHC at the time of writing.
<h3>Taylor Morrison Home's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752010227_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

TMHC

Here's How Much You Would Have Made Owning Taylor Morrison Home Stock In The Last 5 Years

ZSPC

zSpace Enters Stock Purchase Agreement With Tumim Stone Capital; Can Sell Up To $30M Worth Of Shares To Tumim

Shares of power company AES Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AES#NYSE">AES</a>) are surging in Tuesday&#8217;s after-hours session following reports the company has received <a href="https://www.benzinga.com/calendars/m-a">takeover interest</a>.
What To Know: AES is exploring options including a potential sale as multiple large investment firms have expressed interest in acquiring the company, according to <a href="https://www.bloomberg.com/news/articles/2025-07-08/power-firm-aes-explores-options-amid-takeover-interest?embedded-checkout=true">Bloomberg</a>. 
Potential buyers include several major private equity firms and infrastructure investors who are interested after the stock was cut in half over the past two years and has declined approximately 13% year-to-date. 
AES operates a group of renewable power assets and has signed deals to provide renewable power to multiple tech giants.
<h1 class="wp-block-heading">How To Buy AES Stock</h1>
By now you're likely curious about how to participate in the market for AES, be it to purchase shares or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option or sell a call option at a strike price above where shares are currently trading — either way, it allows you to profit from the share price decline.
AES Price Action: <a href="http://benzinga.com/quote/aes">AES shares</a> were up 13.73% at $11.07 in extended trading Tuesday at last check, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/options/25/07/46307541/fslr-stock-big-beautiful-bill-comeback-possible">Options Corner: Why First Solar Can Trump The &#8220;Beautiful&#8221; Blow To Clean Energy</a></li>
</ul>
Photo: Poetra.RH/Shutterstock.com

After-Hours Center

Movers

AES Stock Is Soaring After The Bell: Here's Why

<a href="https://www.bloomberg.com/graphics/2025-china-data-centers-nvidia-chips/">https://www.bloomberg.com/graphics/2025-china-data-centers-nvidia-chips/</a>

NVDA

'China Wants to Use 115,000 Banned Nvidia Chips to Fulfil Its AI Ambitions'- Bloomberg

Starbucks Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) shares are warming up in after-hours Tuesday following reports suggesting the coffee giant has drawn interest from potential investors regarding <a href="https://www.benzinga.com/markets/equities/25/06/46066854/starbucks-denies-full-china-exit-amid-stake-sale-talks-as-market-share-slips-to-14">its China business</a>.
What To Know: After the market close on Tuesday, Bloomberg <a href="https://www.bloomberg.com/news/articles/2025-07-08/starbucks-said-to-draw-interest-for-controlling-stake-in-china?embedded-checkout=true">reported</a> that Starbucks is reviewing proposals from investors potentially interested in taking a controlling stake in the company&#8217;s operations in China. 
People familiar with the matter said the company is in the process of narrowing down some of the interested investors for a subsequent bidding round. 
The report indicates that Starbucks was aiming to sell a minority stake in its China business to a partner who could help return operations to growth, but is now considering selling a controlling stake to a private equity firm or other industry players.
SBUX Price Action: <a href="http://benzinga.com/quote/SBUX">Starbucks shares</a> were up 0.53% in after-hours, trading at $95.44 at the time of publication on Tuesday. The stock closed Tuesday&#8217;s regular session up 1.39% and is now up approximately 4% since the start of the year, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46288023/uber-ceos-mother-refuses-to-buy-starbucks-coffee-thanks-to-her-frugal-beginnings-even-though-her-sons-company-delivers-it-you-got-to-talk-it-up-says-dara">Uber CEO&#8217;s Mother Refuses To Buy Starbucks Coffee Thanks To Her Frugal Beginnings — Even Though Her Son&#8217;s Company Delivers It: &#8216;You Got To Talk It Up&#8217; Says Dara Khosrowshahi</a></li>
</ul>
Photo: Cloudy Design/Shutterstock.com

Global

SBUX

Starbucks Stock Drifts Higher Amid Brewing China Business Sale Chatter

ASML Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) has outperformed the market over the past 15 years by 9.5% on an annualized basis producing an average annual return of 21.75%. Currently, ASML Holding has a market capitalization of $312.24 billion. 
Buying $1000 In ASML: If an investor had bought $1000 of ASML stock 15 years ago, it would be worth $19,554.11 today based on a price of $794.10 for ASML at the time of writing.
<h3>ASML Holding's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752009311_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASML

$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

AGCO

AGCO Corporation And TAFE Enter Fourth Amendment To Agreement; Amendment Extends Expiration Date To November 28, 2025

Management

QNRX

On July 3, 2025, Quoin Pharmaceuticals And CFO Gordon Dunn Agreed To A Mutual Separation Later This Year; Mr. Dunn Will Continue In His Current Role Until His Successor Is Appointed

Dual-active material science solution is ideal for sensitive formulations
AptarGroup, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has developed a dual-active material science technology engineered to simultaneously control moisture and oxygen. This technology is designed to provide a singular solution to address these degradation drivers for pharmaceutical drugs, including oral solid dose glucagon-like peptide-1 (GLP-1), medical devices and more.
This new solution marks a significant material science breakthrough in the pharmaceutical industry, extending Aptar CSP Technologies' <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Faptar.com%2Fproducts%2Fpharmaceutical%2F3-phase-activ-polymer-technology%2F&amp;esheet=54285423&amp;newsitemid=20250708320370&amp;lan=en-US&amp;anchor=3-Phase+Activ-Polymer%26%238482%3B+technology&amp;index=1&amp;md5=2b581606d873326b8f07f68859781d59">3-Phase Activ-Polymer&#x2122; technology</a> into new use cases where a combination of humidity and oxidation can compromise the efficacy, safety, and shelf life of sensitive oral solid dose drugs, medical devices, implantable mesh devices, microarray patches and transdermal delivery systems.

Biotech

Aptar Unveils Dual-Active Material Science Technology To Protect Sensitive Pharma And Medical Devices From Moisture And Oxygen

Ashland Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASH#NYSE">ASH</a>) today provided an update on its $60 million manufacturing network optimization plan, a key initiative under its "execute" strategy. As part of ongoing efforts to enhance operational consistency and profitability, and improve the competitive position of core technologies, the company announced the closure of its manufacturing facility in Parlin, New Jersey, and the transfer of its hydroxyethyl cellulose (HEC) production from Parlin to its Hopewell, Virginia plant. This action is a critical step in building larger scale, improving costs across manufacturing sites and delivering the planned HEC network optimization savings in line with Ashland's timeline. The company also announced the closure of its Chatham, New Jersey plant, and the transfer of its microbial protection production to its Freetown, Massachusetts plant, making progress on the consolidation of its smaller plants into its larger manufacturing sites. Beyond the network optimization, Ashland continues to invest in its future.

Ashland To Close Two New Jersey Plants In $60M Manufacturing Optimization Plan, Shifting Production To Larger Sites

This strategic acquisition enhances Astronics' capabilities in aircraft connectivity, in-seat power, and cabin modifications. FAA Organizational Designation Authorization (ODA) streamlines the process of obtaining FAA Supplemental Type Certificates (STCs) and Parts Manufacturer Approvals (PMAs) for Astronics' products and systems. This added capability positions Astronics to benefit from pent-up demand for aircraft modifications for connectivity, cabin reconfigurations, and lease returns, in a time when ODA services availability is limited. The transaction is valued at approximately $8 million and includes the addition of nine Envoy Aerospace employees to the Astronics team.
Envoy Aerospace, a long-standing and highly experienced ODA, has built a strong reputation based on trust and exceptional service in aircraft and rotorcraft type certification solutions. Envoy Aerospace specializes in helping clients obtain U.S. FAA STCs for major design changes, providing design approvals for new product PMAs, and assisting clients in foreign type approval of their modification programs. Ongoing and future Envoy programs will remain a focus as Astronics integrates the team and capabilities into its broader operations.
"Envoy Aerospace's extensive experience and trusted reputation as an ODA make them a perfect fit for Astronics, supporting our strategic thrust for Inflight Entertainment and Connectivity," said Mike Kuehn, President of Astronics Connectivity Systems and Certifications (CSC). "This will enable dedicated access to ODA services for our collective Astronics and Envoy customers to obtain FAA STCs and PMAs for our products."
"We're honored to welcome Envoy's talented team into the Astronics family and to build on their proven success. We value the relationships with current Envoy Aerospace customers and look forward to further strengthening these partnerships under the Astronics umbrella."
Adrian Honer, Partner at Envoy Aerospace, added, "Envoy has worked with Astronics for more than two decades, making this partnership a natural next step. Joining the Astronics team aligns with our mission to advance aviation safety and innovation. We remain committed to delivering exceptional service in aircraft and rotorcraft type certification as we look to expand our capabilities and reach new milestones together. Together, we're excited to grow and further strengthen a highly skilled ODA services team."
For more information on Astronics and its solutions, visit the <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.astronics.com%2Fultralite-usb-in-seat-power-system&amp;esheet=54287671&amp;newsitemid=20250708258640&amp;lan=en-US&amp;anchor=Astronics+website&amp;index=3&amp;md5=48e173f9645954543db42026876513aa">Astronics website</a>.

ATRO

Astronics Corporation Acquires Envoy Aerospace, An FAA Organization Designation Authorization Services Provider; The Transaction Is Valued At ~$8M

<h3>Gainers</h3>
<ul>
<li>Beasley Broadcast Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBGI#NASDAQ">BBGI</a>) stock moved upwards by 22.0% to $5.1 during Tuesday's after-market session. The company's market cap stands at $7.1 million. </li>
<li>Pop Culture Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPOP#NASDAQ">CPOP</a>) shares moved upwards by 7.86% to $0.67. The company's market cap stands at $8.3 million. </li>
<li>LiveOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVO#NASDAQ">LVO</a>) shares rose 4.96% to $0.81. The company's market cap stands at $81.6 million. </li>
<li>iOThree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOTR#NASDAQ">IOTR</a>) stock increased by 4.79% to $0.43. The company's market cap stands at $10.9 million. </li>
<li>NextPlat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPL#NASDAQ">NXPL</a>) shares moved upwards by 4.44% to $0.78. The company's market cap stands at $20.2 million. </li>
<li>Global Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GITS#NASDAQ">GITS</a>) stock rose 3.71% to $3.35. The market value of their outstanding shares is at $10.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>MediaCo Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDIA#NASDAQ">MDIA</a>) shares decreased by 7.0% to $1.2 during Tuesday's after-market session. The company's market cap stands at $73.5 million. </li>
<li>Mega Matrix (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MPU#AMEX">MPU</a>) stock decreased by 5.72% to $2.31. The company's market cap stands at $61.4 million. </li>
<li>QMMM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QMMM#NASDAQ">QMMM</a>) shares decreased by 4.63% to $1.65. The market value of their outstanding shares is at $84.6 million. </li>
<li>EPWK Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPWK#NASDAQ">EPWK</a>) stock fell 3.83% to $0.5. The market value of their outstanding shares is at $11.1 million. </li>
<li>LQR House (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YHC#NASDAQ">YHC</a>) shares fell 3.78% to $1.91. The market value of their outstanding shares is at $2.0 million. </li>
<li>Urban One (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UONEK#NASDAQ">UONEK</a>) stock declined by 3.0% to $0.59. The market value of their outstanding shares is at $31.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BBGI

CPOP

EPWK

GITS

IOTR

MDIA

NXPL

QMMM

UONEK

12 Communication Services Stocks Moving In Tuesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Calidi Biotherapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CLDI#AMEX">CLDI</a>) shares moved upwards by 24.9% to $0.42 during Tuesday's after-market session. The market value of their outstanding shares is at $7.6 million. </li>
<li>SunLink Health Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) shares increased by 10.0% to $1.1. The company's market cap stands at $7.1 million. </li>
<li>ProKidney (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROK#NASDAQ">PROK</a>) shares increased by 9.91% to $4.1. The market value of their outstanding shares is at $78.5 million. </li>
<li>Inotiv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NOTV#NASDAQ">NOTV</a>) stock rose 9.9% to $2.33. The market value of their outstanding shares is at $70.4 million. </li>
<li>Co-Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CODX#NASDAQ">CODX</a>) shares rose 7.03% to $0.3. The company's market cap stands at $8.7 million. </li>
<li>Wellgistics Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGRX#NASDAQ">WGRX</a>) stock moved upwards by 5.17% to $0.93. The company's market cap stands at $67.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>RxSight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXST#NASDAQ">RXST</a>) stock declined by 33.2% to $8.55 during Tuesday's after-market session. The company's market cap stands at $505.1 million. </li>
<li>Entero Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTO#NASDAQ">ENTO</a>) stock decreased by 18.89% to $0.43. The company's market cap stands at $1.8 million. </li>
<li>Gelteq (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GELS#NASDAQ">GELS</a>) stock declined by 6.85% to $1.77. The market value of their outstanding shares is at $16.1 million. </li>
<li>Rockwell Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMTI#NASDAQ">RMTI</a>) stock fell 6.57% to $0.87. The company's market cap stands at $27.1 million. </li>
<li>Universe Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) stock fell 6.42% to $3.5. The market value of their outstanding shares is at $54.9 million. </li>
<li>Windtree Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) stock fell 5.8% to $0.74. The company's market cap stands at $2.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CLDI

CODX

ENTO

GELS

NOTV

PROK

RMTI

RXST

WGRX

WINT

12 Health Care Stocks Moving In Tuesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Capstone Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPS#NASDAQ">CAPS</a>) shares moved upwards by 5.1% to $1.43 during Tuesday's after-market session. The market value of their outstanding shares is at $7.3 million. </li>
<li>Fuel Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEK#NASDAQ">FTEK</a>) shares increased by 4.71% to $2.97. The company's market cap stands at $89.2 million. </li>
<li>Pitney Bowes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBI#NYSE">PBI</a>) stock moved upwards by 4.68% to $11.55. The market value of their outstanding shares is at $2.0 billion. </li>
<li>Singularity Future Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGLY#NASDAQ">SGLY</a>) stock rose 4.65% to $0.98. The company's market cap stands at $4.2 million. </li>
<li>DLH Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLHC#NASDAQ">DLHC</a>) shares rose 4.36% to $5.98. The company's market cap stands at $81.1 million. </li>
<li>Smart Powerr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CREG#NASDAQ">CREG</a>) shares increased by 3.84% to $0.24. The market value of their outstanding shares is at $5.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Vertical Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVTL#NYSE">EVTL</a>) stock decreased by 21.4% to $5.46 during Tuesday's after-market session. The company's market cap stands at $580.8 million. </li>
<li>Ryde Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/RYDE#AMEX">RYDE</a>) shares declined by 10.42% to $0.41. The company's market cap stands at $10.9 million. </li>
<li>Expion360 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XPON#NASDAQ">XPON</a>) stock fell 9.1% to $0.86. The market value of their outstanding shares is at $2.9 million. </li>
<li>Elong Power Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELPW#NASDAQ">ELPW</a>) shares fell 6.57% to $1.85. The market value of their outstanding shares is at $96.1 million. </li>
<li>Silynxcom (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SYNX#AMEX">SYNX</a>) shares fell 6.03% to $1.56. The company's market cap stands at $11.0 million. </li>
<li>Stem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STEM#NYSE">STEM</a>) shares fell 4.54% to $8.63. The company's market cap stands at $73.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CAPS

CREG

DLHC

ELPW

EVTL

FTEK

RYDE

SGLY

STEM

SYNX

XPON

12 Industrials Stocks Moving In Tuesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Sobr Safe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) shares increased by 46.3% to $4.93 during Tuesday's after-market session. The company's market cap stands at $4.2 million. </li>
<li>WidePoint (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/WYY#AMEX">WYY</a>) shares rose 6.58% to $3.4. The company's market cap stands at $31.8 million. </li>
<li>Bit Origin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTOG#NASDAQ">BTOG</a>) shares increased by 5.77% to $0.23. The market value of their outstanding shares is at $15.0 million. </li>
<li>Wolfspeed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) shares increased by 5.54% to $2.66. The company's market cap stands at $359.4 million. </li>
<li>Intchains Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICG#NASDAQ">ICG</a>) shares rose 5.17% to $2.64. The company's market cap stands at $123.3 million. </li>
<li>Argo Blockchain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBK#NASDAQ">ARBK</a>) shares moved upwards by 3.62% to $0.3. The market value of their outstanding shares is at $16.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Aehr Test System (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) shares decreased by 20.7% to $12.03 during Tuesday's after-market session. The company's market cap stands at $441.2 million. As per the press release, Q4 earnings came out today. </li>
<li>BTCS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTCS#NASDAQ">BTCS</a>) stock declined by 19.63% to $4.75. The company's market cap stands at $59.0 million. </li>
<li>Ascent Solar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTI#NASDAQ">ASTI</a>) stock declined by 9.37% to $2.13. The company's market cap stands at $5.9 million. </li>
<li>Penguin Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENG#NASDAQ">PENG</a>) stock declined by 7.52% to $19.6. The company's market cap stands at $1.1 billion. The company's, Q3 earnings came out today. </li>
<li>Sequans Communications (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQNS#NYSE">SQNS</a>) stock fell 4.86% to $1.96. The market value of their outstanding shares is at $36.4 million. </li>
<li>Creative Global Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGTL#NASDAQ">CGTL</a>) shares fell 4.28% to $1.12. The company's market cap stands at $25.2 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEHR

ARBK

ASTI

BTCS

BTOG

CGTL

Penguin Solutions, Inc. - Ordinary Shares

PENG

SOBR

SQNS

WOLF

12 Information Technology Stocks Moving In Tuesday's After-Market Session

7 analysts have shared their evaluations of Freeport-McMoRan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $45.0, a high estimate of $50.00, and a low estimate of $39.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 3.23%. 
<img src="https://www.benzinga.com/files/images/story/2025/1752008461_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Freeport-McMoRan among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alexander Hacking</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$48.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>Orest Wowkodaw</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$48.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Orest Wowkodaw</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$43.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Chris LaFemina</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$50.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Timna Tanners</td>
<td>Wolfe Research</td>
<td>Announces</td>
<td>Outperform</td>
<td>$39.00</td>
<td>-</td>
</tr>
<tr>
<td>Daniel Major</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$45.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Bill Peterson</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$42.00</td>
<td>$52.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Freeport-McMoRan. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Freeport-McMoRan compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Freeport-McMoRan's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Freeport-McMoRan's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/FCX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Freeport-McMoRan analyst ratings.</a>
<h2>Delving into Freeport-McMoRan's Background</h2>
Freeport-McMoRan owns stakes in 10 copper mines, led by its 49% ownership of the Grasberg copper and gold operations in Indonesia, 55% of the Cerro Verde mine in Peru, and 72% of Morenci in Arizona. It sold around 1.2 million metric tons of copper (its share) in 2024, making it the one of the world's largest copper miners by volume. It also sold about 900,000 ounces of gold, mostly from Grasberg, and 70 million pounds of molybdenum. It had about 25 years of copper reserves at the end of December 2024. We expect it to sell similar amounts of copper midcycle in 2029, though we expect gold volumes to decline to about 700,000 ounces then due to falling production at Grasberg.
<h3>Freeport-McMoRan: Delving into Financials</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Freeport-McMoRan's revenue growth over a period of 3M has faced challenges. As of 31 March, 2025, the company experienced a revenue decline of approximately -9.38%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.
Net Margin: Freeport-McMoRan's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 6.15%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 2.0%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Freeport-McMoRan's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.64%, the company may face hurdles in achieving optimal financial performance.
Debt Management: With a high debt-to-equity ratio of 0.53, Freeport-McMoRan faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Significance of Analyst Ratings Explained</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Freeport-McMoRan Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)

Root (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $140.33, a high estimate of $170.00, and a low estimate of $105.00. This upward trend is apparent, with the current average reflecting a 38.49% increase from the previous average price target of $101.33.
<img src="https://www.benzinga.com/files/images/story/2025/1752008453_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Root. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Kligerman</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Hold</td>
<td>$125.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Thomas McJoynt-Griffith</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$170.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$142.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Thomas McJoynt-Griffith</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$150.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Yaron Kinar</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$150.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$105.00</td>
<td>$97.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Root. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Root compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Root's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Root's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ROOT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Root analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Discovering Root: A Closer Look</h2>
Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. It generates revenue from the sales of auto insurance policies within the United States.
<h3>Financial Milestones: Root's Journey</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Root displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 37.07%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Root's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 5.27%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Root's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 8.51%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.19%, the company showcases effective utilization of assets.
Debt Management: Root's debt-to-equity ratio surpasses industry norms, standing at 0.87. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>The Basics of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ROOT

Beyond The Numbers: 6 Analysts Discuss Root Stock

Comments

Kemper Corporation 5.875% Fixed-Rate Reset Junior Subordinated Debentures due 2062

Kemper Corporation 5.875% Fixed-Rate Reset Junior Subordinated Debentures due 2062 (KMPB) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO